- The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional studyShrividya Iyer
Global Health Economics and Outcomes Research, Pfizer Inc, 235, E 42nd Street, New York, NY, 10017, USA
Support Care Cancer 22:181-7. 2014..The main objective of our study was to assess patient-reported outcomes and the degree of concordance between physician and patient perceptions of symptom severity in advanced NSCLC in the USA...
- Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and GermanyShrividya Iyer
Pfizer Oncology, New York, NY 10017, USA
Lung Cancer 81:288-93. 2013..To assess patient reported symptom burden and impact on disease specific health related quality of life (HRQOL) in advanced non-small cell lung cancer (NSCLC) patients...
- Effect of subcutaneous methylnaltrexone on patient-reported constipation symptomsShrividya S Iyer
Pfizer Inc, Collegeville, PA, USA
Value Health 14:177-83. 2011..Methylnaltrexone, a selective peripheral acting mu-opioid receptor antagonist, alleviates the constipating effects of opioids without affecting centrally mediated analgesia...